WILMINGTON, Del., Feb. 14, 2013 /PRNewswire/ -- SPI Pharma, Inc. (Wilmington, DE), a global leader in providing pharmaceutical ingredients and technologies for patient-friendly dosage forms, announces ...
Crunch time is rapidly approaching in Roquette?s long-running patent dispute with SPI Pharma, with the case scheduled to go to trial on 4th October 2010. Crunch time is rapidly approaching in Roquette ...
NEW CASTLE, Del.--(BUSINESS WIRE)--Oct. 6, 2004--To increase its presence in the nutritional supplement market, SPI Pharma has selected ChemPoint.com to be its sole channel for this market. Under the ...
Pharmaburst was the first fully formulated off-the-shelf orally disintegrating technology designed for direct compression tablet manufacturing on the market. It is now used in more than 60 ...
The MarketWatch News Department was not involved in the creation of this content. WILMINGTON, Del., July 24, 2024 /PRNewswire-PRWeb/ -- SPI Pharma introduces Valens(TM) as a new portfolio brand name ...
UltraBurst has a high disintegration speed, which is for all market segments, from prescriptions to nutraceuticals. SPI Pharma introduced an excipient platform for flash orally disintegrating tablets ...
SPI Pharma, Inc.: Offering broader access to sustainable and scalable pharma-grade saponin adjuvants
SPI Pharma, Inc. and Q-Vant Biosciences, Inc. announce a strategic partnership which includes an investment to expand Q-Vant's proprietary 100% sustainable Q-SAP technology, and the signing of an ...
WILMINGTON, Del., July 16, 2024 /PRNewswire/ -- SPI Pharma, Inc. a global leader in biopharmaceutical excipient and adjuvant systems, and Inimmune, Corp., a pioneering biotechnology company ...
WILMINGTON, Del., Jan. 14, 2014 /PRNewswire/ -- SPI Pharma is proud to announce the launch of the new Pharmaburst 500 website (www.pharmaburst.com). The new website was designed to assist both R&D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback